
Chase 1000mg Injection
Marketer
Shreshtha Formulations
Salt Composition
Cefepime (1000mg)
Overview Chase 1000mg Injection
Cefotaxime 1000mg Injection is a powerful antibacterial agent combating bacterial infections. It's indicated for serious bacterial infections affecting the skin, respiratory system, gastrointestinal tract, urinary system, and bloodstream. Its mechanism involves bacterial cell destruction. Importantly, it's ineffective against viral infections. Cefotaxime 1000mg Injection is frequently administered to hospitalized patients with critical illnesses. Administration is intravenous, either by infusion or direct injection, always under professional medical guidance. Dosage is individualized, considering infection type, location, and severity. Continue the prescribed injection course even with symptom improvement; premature cessation risks relapse or exacerbation. Adverse reactions, such as skin rash, pruritus, nausea, emesis, cephalalgia, pyrexia, diarrhea, or localized injection site inflammation, may occur; these are usually transient and resolve with continued therapy. Report persistent or bothersome side effects to your physician. Prior to commencing treatment, disclose any pre-existing renal or hepatic impairment, or antibiotic allergies. Regular blood tests to assess renal function may be recommended during treatment. Generally, this medication is considered safe during pregnancy and lactation under medical supervision.
Primary Ingredients of Chase 1000mg Injection
No text provided to rephrase.
Uses of Chase 1000mg Injection
Managing life-threatening bacterial diseases
Major Benefits of Chase 1000mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Chase 1000mg Injection:
- Injection site reactions (pain, swelling, redness)
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
- Increased prothrombin time
- Decreased phosphate level in blood
- Increased partial thromboplastin time (PTT)
How to use Chase 1000mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Chase 1000mg Injection works:
Chase 1000mg Injection is a bactericidal antibiotic that works by disrupting bacterial cell wall synthesis, a process essential for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with concurrent alcohol and Chase 1000mg Injection use.
PregnancySAFE IF PRESCRIBED
The administration of 1000mg Chase Injection is typically deemed safe for pregnant individuals. Preclinical trials using animal models have indicated minimal or no negative consequences for fetal development; however, research involving human subjects is currently restricted.
Breast feedingSAFE IF PRESCRIBED
Chase 1000mg Injection is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no apparent risk to infants. However, extended use of Chase 1000mg Injection should be avoided due to potential side effects including skin rashes and diarrhea.
DrivingCONSULT YOUR DOCTOR
The effect of a 1000mg Chase injection on driving ability is undetermined. Refrain from driving if any symptoms impair concentration or reaction time.
KidneyCAUTION
Administering Chase 1000mg Injection requires careful consideration in individuals with impaired renal function. Dosage modification of Chase 1000mg Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Chase 1000mg Injection in individuals with hepatic impairment is likely safe. Existing evidence indicates dose modification may be unnecessary; however, medical advice is recommended.
What if you forget to take Chase 1000mg Injection :
Omit a Chase 1000mg Injection dose? Seek medical advice immediately.
Facts to Know About Chase 1000mg Injection
| Label | Value |
|---|---|
| Chemical Type | Cephalosporins (3rd and 4th generation) |
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
| Behavior Class | Fourth-Generation Cephalosporins |
